Spots Global Cancer Trial Database for seborrheic keratosis
Every month we try and update this database with for seborrheic keratosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of A-101 for the Treatment of Seborrheic Keratosis | NCT02260180 | Seborrheic Kera... | A-101 | 18 Years - 75 Years | Aclaris Therapeutics, Inc. | |
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study | NCT03846531 | Lesion Skin Seborrheic Kera... | Nano-Pulse Stim... | 18 Years - 75 Years | Pulse Biosciences, Inc. | |
An Open-Label Safety Study of A-101 Solution | NCT02667288 | Seborrheic Kera... | A-101 Solution | 18 Years - | Aclaris Therapeutics, Inc. | |
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study | NCT04249115 | Lesion Skin Seborrheic Kera... Skin Lesion Benign Skin Tum... | Nano-Pulse Stim... | 21 Years - 75 Years | Pulse Biosciences, Inc. | |
Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis | NCT05136144 | Seborrheic Kera... | SM-020 | 18 Years - | DermBiont, Inc. | |
Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis | NCT01214564 | Seborrheic Kera... | PEP005 (ingenol... | 18 Years - | Peplin | |
Fast Track Diagnosis of Skin Cancer by Advanced Imaging | NCT04229277 | Malignant Melan... Nevus, Pigmente... Basal Cell Carc... Seborrheic Kera... | optical coheren... | 18 Years - | University Hospital Bispebjerg and Frederiksberg | |
Optical Biopsy of Human Skin in Conjunction With Laser Treatment | NCT00540566 | Malignant Melan... Merkel Cell Car... Basal Cell Carc... Squamous Cell C... Atypical Nevi Congenital Nevi Seborrheic Kera... Paget's Disease Dermatofibroma Kaposi's Sarcom... Port Wine Stain Hemangioma Tattoos Scleroderma Burns | Optical Biopsy ... | 18 Years - 75 Years | University of California, Irvine | |
Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses? | NCT01159860 | Seborrheic Kera... | cryosurgery Curettage | 18 Years - 75 Years | Milton S. Hershey Medical Center | |
Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors | NCT06046144 | Basal Cell Carc... Lentigo Maligna Melanoma Nevus Seborrheic Kera... Lentigo | Fluorescence-Ad... Reflectance con... Super-high magn... | - | Centre Hospitalier Universitaire de Saint Etienne | |
A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis | NCT03148691 | Seborrheic Kera... | A-101 | 18 Years - | Aclaris Therapeutics, Inc. | |
Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis | NCT02160626 | Seborrheic Kera... | A-101 Vehicle A-101 (40) Topi... A-101 (32.5) To... | 18 Years - | Aclaris Therapeutics, Inc. | |
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage | NCT04688749 | Melanoma (Skin) Basal Cell Carc... Squamous Cell C... Dysplastic Nevu... Lentigo Maligna Seborrheic Kera... Lichen Planus-L... Carcinosarcoma | Electrical Impe... | 8 Years - 90 Years | Aristotle University Of Thessaloniki | |
Study of A-101 for the Treatment of Seborrheic Keratosis | NCT02260180 | Seborrheic Kera... | A-101 | 18 Years - 75 Years | Aclaris Therapeutics, Inc. | |
Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis | NCT05136144 | Seborrheic Kera... | SM-020 | 18 Years - | DermBiont, Inc. | |
A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis | NCT02667275 | Seborrheic Kera... | A-101 Solution Vehicle Solutio... | 18 Years - | Aclaris Therapeutics, Inc. | |
A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. | NCT02667236 | Seborrheic Kera... | A-101 Solution Vehicle Solutio... | 18 Years - | Aclaris Therapeutics, Inc. | |
Fast Track Diagnosis of Skin Cancer by Advanced Imaging | NCT04229277 | Malignant Melan... Nevus, Pigmente... Basal Cell Carc... Seborrheic Kera... | optical coheren... | 18 Years - | University Hospital Bispebjerg and Frederiksberg | |
Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors | NCT06046144 | Basal Cell Carc... Lentigo Maligna Melanoma Nevus Seborrheic Kera... Lentigo | Fluorescence-Ad... Reflectance con... Super-high magn... | - | Centre Hospitalier Universitaire de Saint Etienne | |
Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis | NCT02160626 | Seborrheic Kera... | A-101 Vehicle A-101 (40) Topi... A-101 (32.5) To... | 18 Years - | Aclaris Therapeutics, Inc. | |
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis | NCT01986920 | Seborrheic Kera... | A-101 25% A-101 32.5% A-101 40% A-101 Vehicle | 18 Years - | Aclaris Therapeutics, Inc. | |
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses | NCT03487588 | Seborrheic Kera... | A-101 Topical S... | 30 Years - 75 Years | Aclaris Therapeutics, Inc. | |
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage | NCT04688749 | Melanoma (Skin) Basal Cell Carc... Squamous Cell C... Dysplastic Nevu... Lentigo Maligna Seborrheic Kera... Lichen Planus-L... Carcinosarcoma | Electrical Impe... | 8 Years - 90 Years | Aristotle University Of Thessaloniki | |
A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. | NCT02667236 | Seborrheic Kera... | A-101 Solution Vehicle Solutio... | 18 Years - | Aclaris Therapeutics, Inc. |